|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Amyloid Beta (N3pE-40) ELISA Assay | ACTH ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Insulin-like Growth Factor-II (IGF-II) ELISA | Leishmania infantum IgG ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27418 | BM7023 | TM09036 | E30 | IB79808 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of Human Aß (N3pE-40) in brain tissue extract. For research use only, not for use in diagnostic procedures. | Enzyme-linked immunosorbent assay (ELISA) for the determination of ACTH (Adrenocorticotropic Hormone) in human plasma. 510(k) cleared. This assay is intended for in-vitro diagnostic use. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the determination of IGF-II in human serum, plasma, urine, saliva, and cell culture supernatants. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of antibodies against Leishmania infantum in human serum or plasma (citrate). For research use only, not for use in diagnostic procedures. |
| Detection Target | Anti-Cetuximab (Erbitux®) | Amyloid Beta (1-x) | sAPP Total | Corynebacterium diphtheriae toxin IgG | Epstein-Barr Virus (EBNA-1) IgG |
| Sample Type | Serum and plasma. | Blood Plasma, CSF, Serum, Cell Culture Media, Extract from Brain Tissue | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Serum, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 3.13 to 200 pg/mL | 5 to 165 pg/mL | Anti-Ustekinumab (Stelara®) | 0.45 to 9.00 ng/mL | Inquire |
| Sensitivity | 1.5 ng/mL | 3.55 pg/mL | 0.06 ng/mL | 100% (95% confidence interval: 95.44% - 100%) | 0.62 U/mL |
| Assay Time | Overnight + 1 hr 30 mins (incubation) | 4 hrs 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 3 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |